Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Monday is looking like a SWINE FLU speculative flu stock stock bonanza, and we want to caution about some of the lessons of scares in the past of SARS, bird flu, Mad Cow, and even hoof & mouth as similar references.  The two approved drug treatments, not vaccines, which are being released are Tamiflu made by Roche (OTC: RHHBY) and Relenza made by GlaxoSmithkline (NYSE: GSK).  Gilead Sciences, Inc. (GILD) gets royalties from Roche for Tamiflu, and its shares are indicated north of $48.00 after a $45.80 close on Friday.  There are also waves of tier-two and tier-three stocks which could move on this news, but be advised that we have seen these pops in the past from SARS and Bird Flu which were followed ultimately by lower share prices and many of the speculative players disappeared.

Of the tier-two stocks, you have BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) and Novavax, Inc. (NASDAQ: NVAX).  Of the tier-three stocks you have Generex Biotechnology Corp. (NASDAQ: GNBT), Vical Inc. (NASDAQ: VICL), AVI Biopharma, Inc. (NASDAQ: AVII), and Crucell NV (NASDAQ: CRXL).  More descriptive data has been provided for each move.   On another scale, Smithfield Foods Inc. (NYSE: SFD), the iShares MSCI Mexico Investable Market Index (NYSE: EWW), and The Mexico Fund, Inc. (NYSE: MXF) have exposure here as well.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) was up big Friday as it is a maker of drugs that block key enzymes in viral diseases like the flu, shares are indicated over $3.00 after a $2.21 close on Friday.  Novavax, Inc. (NASDAQ: NVAX) is another clinical stage company using its virus-like particle platform technology for flu treatments; stock is indicated north of $2.50 after closing up some 75% at $1.42 Friday.

Generex Biotechnology Corp. (NASDAQ: GNBT) is being passed around as a penny stock flu player with shares indicated around $0.40 after closing up 25% at almost $0.34 Friday.  Vical Inc. (NASDAQ: VICL) closed up 3% Friday at $2.53 and shares are indicated up around $3.00.  AVI Biopharma, Inc. (NASDAQ: AVII) rose over 20% to $0.89 Friday and shares are indicated up marginally as a result.  Crucell NV (NASDAQ: CRXL) has a faster way of making flu vaccines. This closed up 1% on Friday and is hardly moving.

This could have an impact on food stocks and even an ETF and a closed-end fund that each track Mexico.  Smithfield Foods Inc. (NYSE: SFD) is deemed as the big pork play among the U.S. food companies.  There are also two plays on the fund side with a closed-end fund and an ETF.  The iShares MSCI Mexico Investable Market Index (NYSE: EWW) may be taking a hard hit this morning because of the Mexico-tied swine flu being the source of the disease.  There have been more than 1,300 suspected cases and roughly 100 deaths from swine flu.  This is the key ETF that traders use to trade exposure to Mexico.  The Mexico Fund, Inc. (NYSE: MXF) is a closed-end mutual fund that may also take a hard hit this morning because of the Mexico-tied swine flu being the source of the disease.

Those who believe that the sky is falling will point back to the flu scare of 1918 that decimated populations.  Keep in mind that there was little communication and the treatment at the time was generally bed rest and no hygiene was practiced by the bulk of the population.   You can probably bet that you will be hearing “squeal like a pig!” jokes sooner rather than later.

As a reminder, these huge gap-ups can last more than a day, but historically we have seen each successive move usually being less than the first.  As with issues such as SARS and bird flu, the world did not end and it was only the SARS scare which actually caused real damage.  We also had the great Mad Cow disease craze and even teh Hoof & Mouth scare, all of which created initial moves but ultimately had zero net impact on sectors and the economy as a whole.

JON C. OGG

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618